Therapeutic efficacy of upadacitinib in refractory juvenile idiopathic arthritis: a case report. [PDF]
Li N, Zhang H, Dai B.
europepmc +1 more source
Objective Rheumatoid arthritis (RA) is characterized by anti‐modified protein antibodies (AMPAs), including anti‐citrullinated protein antibodies (ACPA), anti‐carbamylated protein antibodies (anti‐CarP), and anti‐acetylated protein antibodies (AAPA). In contrast to other AMPAs, AAPA IgM is found in healthy individuals, raising questions about its role ...
Aegli Athanasiadou +10 more
wiley +1 more source
Evaluation of ferroptosis markers and laboratory findings in patients with juvenile idiopathic arthritis. [PDF]
Dogantan S +5 more
europepmc +1 more source
Objective Microbial small RNAs can regulate human genes. Higher plasma concentrations of microbial transfer RNA (tRNA)‐derived RNA‐1 (tDR‐1) were previously associated with lower rheumatoid arthritis (RA) disease activity. This study examined whether tDR‐1 concentrations differ in anticyclic citrullinated peptide‐3 positive (CCP3+) at‐risk individuals (
Anastasiia Phothisane +11 more
wiley +1 more source
Inflammation-driven bone erosion and reactive remodeling in experimental arthritis revealed by cortical bone surface analysis. [PDF]
Nguyen A +10 more
europepmc +1 more source
Septic arthritis caused by Nocardia asiatica: a case report and narrative review. [PDF]
Yildiz M.
europepmc +1 more source
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review. [PDF]
Pang M, Li L, Zhang Q, Zhao M.
europepmc +1 more source
Risk factors for cerebral infarction in patients with rheumatoid arthritis: a retrospective case-control study. [PDF]
Xuan J, Gao X.
europepmc +1 more source
Impact of etanercept on the progression of undifferentiated arthritis to rheumatoid arthritis: A prospective observational study in China. [PDF]
Shen J +5 more
europepmc +1 more source
Research Progress on Self-Assembling Delivery Systems in Rheumatoid Arthritis. [PDF]
Yu LL +6 more
europepmc +1 more source

